Sánchez-de la Rosa, R., García-Bujalance, L., & Meca-Lallana, J. (2015). Cost analysis of glatiramer acetate versus interferon-β for relapsing-remitting multiple sclerosis in patients with spasticity: The Escala study. Health Econ Rev.
शिकागो स्टाइल उद्धरणSánchez-de la Rosa, Rainel, Laura García-Bujalance, और José Meca-Lallana. "Cost Analysis of Glatiramer Acetate Versus Interferon-β for Relapsing-remitting Multiple Sclerosis in Patients With Spasticity: The Escala Study." Health Econ Rev 2015.
एमएलए उद्धरणSánchez-de la Rosa, Rainel, Laura García-Bujalance, और José Meca-Lallana. "Cost Analysis of Glatiramer Acetate Versus Interferon-β for Relapsing-remitting Multiple Sclerosis in Patients With Spasticity: The Escala Study." Health Econ Rev 2015.